Can Cell Therapies Take on Solid Tumors?
Download our 2021 supplement dedicated to advances in cell and gene therapies to find out
Stephanie Vine | | Longer Read
sponsored by Bio-Rad Laboratories, MilliporeSigma, Cytiva
Cell therapies have accomplished much, but what lies ahead?
In our 2021 supplement dedicated to cell and gene therapies, experts explain the progress being made in using advanced therapies to tackle solid tumors. If the research comes to fruition, then new approaches will also be needed for manufacturing – since the industry would need to produce enough therapies to treat the hundreds of thousands of patients who could potentially benefit. Download our supplement to read the views of Bruce Levine (University of Pennsylvania), Elliot Norry (Adaptimmune), Tony Ting (Bone Therapeutics), and Fabian Gerlinghaus (Cellares).
Also covered in the supplement:
- The challenges of ensuring raw materials are free of endotoxins
- Gene therapy purification
- The skills gap
- And more!
You can find out more about the supplement and download the PDF here.
Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.
